
Clinical Trials & Research
Targeting Hormone Production in Prostate Cancer: How it Could Impact your Treatment
April 2nd, 2026 | Clinical Trials & ResearchThe Role of PARP Inhibitors in Prostate Cancer Management
February 10th, 2026 | Clinical Trials & Research
What Are PARP Inhibitors? PARP inhibitors (often called PARPi) are cancer medicines you take as pills. PARP is a protein your cells use to fix small breaks in their DNA. PARP inhibitors block this repair process. When cancer cells can’t fix their DNA damage, they may stop growing or die. PARP inhibitors studied and used […]
T-Cell Engager Therapy for Prostate Cancer: An Easy-to-Understand Guide
January 27th, 2026 | Clinical Trials & Research
Prostate cancer is often treatable. Many people do well with surgery, radiation, or hormone therapy. However, sometimes the cancer comes back. Sometimes it spreads to other parts of the body. When that happens, doctors and researchers look for new options. One option being studied is a T-cell engager therapy. It is a type of immunotherapy that […]









